TALK @ PhilMusic.com - The Online Home of the Pinoy Musician

Anything Goes => Kalusugan, Kakisigan at Kaayusan => Topic started by: mozart123 on September 12, 2018, 08:47:43 PM

Title: Price Tussle Starts Over $371,000 Breakthrough Cancer Drug
Post by: mozart123 on September 12, 2018, 08:47:43 PM
Novartis AGís breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its hefty cost.

In Germany, Novartis has set a price of 320,000 euros ($371,000) thatís now subject to negotiation with authorities, Pascal Touchon, head of the drugmakerís cell and gene therapy business, said in an interview. Thatís the list price to treat a form of childhood leukemia and a type of lymphoma in adults. Similar discussions are playing out elsewhere in Europe.


https://www.bloomberg.com/news/articles/2018-09-12/novartis-faces-price-tussle-in-europe-after-cancer-breakthrough?utm_source=facebook&utm_medium=social&cmpid=socialflow-facebook-business&utm_content=business&utm_campaign=socialflow-organic
Title: Re: Price Tussle Starts Over $371,000 Breakthrough Cancer Drug
Post by: marzi on September 17, 2018, 01:04:34 PM
if its a proven treatment for all forms of cancer, it wont be long before someone reverse engineers its composition and make it at a low low price.

"may ritemed ba nyan?"
Title: Re: Price Tussle Starts Over $371,000 Breakthrough Cancer Drug
Post by: mozart123 on September 17, 2018, 05:45:07 PM
if its a proven treatment for all forms of cancer, it wont be long before someone reverse engineers its composition and make it at a low low price.

"may ritemed ba nyan?"

10 years ang patent ng mga gamot it won't be long magkakaroon ng generic yan.